prostate cancer,
Showing 1 - 25 of >10,000
Localized Prostate Cancer, Low Risk Prostate Cancer, Intermediate Risk Prostate Cancer Trial (3 fractions of prostate SBRT)
Not yet recruiting
- Localized Prostate Cancer
- +2 more
- 3 fractions of prostate SBRT
- (no location specified)
Oct 31, 2023
Prostate Cancer, Kinesiophobia, Physical Inactivity Trial in Konya (survey evaluation)
Enrolling by invitation
- Prostate Cancer
- +2 more
- survey evaluation
-
Konya, Selcuklu, TurkeySelcuk University
Nov 16, 2023
Prostate Cancer Trial in Boston (Precision screening intervention, Usual care)
Not yet recruiting
- Prostate Cancer
- Precision screening intervention
- Usual care
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jun 21, 2023
Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)
Not yet recruiting
- Prostate Cancer
- Newly-Diagnosed Prostate Cancer
- (no location specified)
Nov 3, 2023
HER2 Expression and Clinical Pathological Characteristics in
Recruiting
- HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
- Collect HER2 expression in prostate cancer patients
-
Jinan, Shandong, ChinaQilu hospital
Nov 17, 2023
Value of Ultra-fast Prostate MRI in Prostate Cancer
Not yet recruiting
- Prostate Cancer
- Prostate MRI
-
Zurich, ZH, SwitzerlandUniversity Hospital Zurich
Jun 11, 2023
All-in-One Prostate Cancer Staging With MRI
Recruiting
- Prostate Cancer
- Prostate Cancer Patients
-
Brescia, BS, Italy
- +2 more
Oct 3, 2023
Optimizing Announcement of Advanced or Metastatic Prostate
Not yet recruiting
- Prostate Cancer
- Animated video
-
Neuilly-sur-Seine, France
- +2 more
Oct 31, 2023
Cognitive Fusion Prostate Biopsy With Biparametric Magnetic
Recruiting
- Prostate Cancer
- Prostate Cancer Diagnosis
- fusion cognitive prostate biopsy
-
Alicante, SpainUniversidad Miguel Hernández de Elche
Apr 18, 2023
Non-Invasive Biomarkers in Prostate Cancer Disease Management
Recruiting
- Prostate Cancer
- Genomic and Histological Evaluation
-
Tampa, FloridaMoffitt Cancer Center
Nov 16, 2023
Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)
Recruiting
- Metastatic Prostate Cancer
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 17, 2023
Prospective Androgen Receptor Signaling Inhibitors Resistance
Not yet recruiting
- Prostate Cancer
- +3 more
- (no location specified)
Nov 15, 2023
PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)
Not yet recruiting
- PROSTATE CANCER
- +2 more
- Supervised Circuit Training
-
Boston, Massachusetts
- +2 more
Sep 13, 2023
Prostate Cancer Trial (CARE-PC Web-Based Application)
Not yet recruiting
- Prostate Cancer
- CARE-PC Web-Based Application
- (no location specified)
Oct 2, 2023
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
Prostate Cancer Trial in Boston (Ride Share)
Not yet recruiting
- Prostate Cancer
- Ride Share
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 12, 2023
Prostate Carcinoma Trial in Philadelphia (ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal
Not yet recruiting
- Prostate Carcinoma
- ultiparametric Magnetic Resonance Imaging
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 29, 2023
Prostate Cancer, Prostatic Tumors Trial in Boston (High-Intensity Interval Training Exercise Program)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
- High-Intensity Interval Training Exercise Program
-
Boston, Massachusetts
- +1 more
Jun 23, 2023
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer
- Rezvilutamide
- +2 more
- (no location specified)
Nov 10, 2023
Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco
Not yet recruiting
- Castrate Resistant Prostate Cancer
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 1, 2023
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Recurrent Prostate Cancer Patients
Not yet recruiting
- Recurrent Prostate Cancer
-
San Francisco, CaliforniaPower Life Sciences
Sep 30, 2023
Prostate Cancer Trial (HRS-9815 injection)
Not yet recruiting
- Prostate Cancer
- HRS-9815 injection
- (no location specified)
Sep 25, 2023
Prostate Cancer Trial in Porto (e-Health intervention to promote mental and sexual health of prostate cancer survivors)
Recruiting
- Prostate Cancer
- e-Health intervention to promote mental and sexual health of prostate cancer survivors
-
Porto, PortugalFaculty of Psychology and Educational Sciences
Jul 13, 2023